Role of cytochrome P450 genotype in the steps toward personalized drug therapy
Larisa H. Cavallari, Jeong, Adam Phillip Bress
- ISSN / E-ISSN
- — / —
- DOI
- 10.2147/pgpm.s15497 ↗
- Volume · Issue · Pages
- 4 · — · 123-123
- Publisher
- Dove Medical Press Ltd.
- Article URL
- https://doi.org/10.2147/pgpm.s15497 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Nov 2011
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Nov 2011 | OpenAlex |
Keywords (as given): cytochrome P450; pharmacogenomics; CYP2D6; CYP2C9; CYP2C19; genetic polymorphism; individualized drug therapy; drug metabolism; adverse drug reactions; thioridazine; warfarin; clopidogrel; codeine; loss-of-function alleles; dose adjustment; anticoagulation; ventricular arrhythmias; opioid toxicity; FDA labeling
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Pharmacogenomics and Personalized Medicine
- Publication date used
- 01 Nov 2011 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.